Skip to main content
Clinical Trials/CTRI/2013/07/003803
CTRI/2013/07/003803
Recruiting
Phase 2

A single blinded, single centered study, to assess the efficacy of investigational product for its moisturization on healthy human female subjects. - None

Hindustan Unilever Limited0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Hindustan Unilever Limited
Enrollment
40
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Volunteer in generally good health.
  • 2\.Volunteer between the age group of 20 and 40 years.
  • 3\.Volunteer with Normal to dry skin type.
  • 4\.Volunteer has not participated in a similar clinical investigation in the past four weeks
  • 5\.Volunteer willing to abstain from using any cosmetic product on face, besides the provided product during the entire study course.
  • 6\.Volunteer willing to visit the site at specified frequencies for periodic evaluations.
  • 7\.Volunteer willing to comply with study specific requirements.
  • 8\.Volunteer willing to give a written informed consent and come for regular observation.

Exclusion Criteria

  • 1\.A known history or present condition of allergic response to any cosmetic products.
  • 2\.Volunteer with known allergy/ sensitivity to cosmetic products or fragrance and without any skin allergies / infections.
  • 3\.Volunteer under any dermatological treatment / prescribed medications.
  • 4\.Skin disease (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations on the scalp), which would interfere with the test readings.
  • 5\.On medications (e.g. steroids or antihistamines), which would compromise the study.
  • 6\.Currently or has been undergoing dermatologist facial treatments or procedures within the last 1 month.
  • 7\.Volunteer; pregnant or nursing.
  • 8\.Volunteer viewed by the investigator as not being able to complete the study or participating in another study.

Outcomes

Primary Outcomes

Not specified

Similar Trials